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Abstract: INTRODUCTION Neurogenic lower urinary tract dysfunction (NLUTD) represents a severe
burden for patients with open spina bifida (OSB). The effect of fetal OSB repair on the urological
outcome remains unclear, as controversial data exist. The aim of this study was to further increment
existing outcome data and to demonstrate that our earlier published positive preliminary results are not
erratic. METHODS Data from standardized urological follow-up appointments of patients with fetal
OSB repair operated at our center were analyzed. Data were obtained from urodynamic studies (UDSs)
and radiologic exams performed in the newborn (gestational age 37-39 weeks), at ages of 6, 12, 18, and
24 months, and then at yearly intervals. RESULTS Of 82 patients (mean age 2.6 years, range 6 months
to 7 years), 26 (32%) had a normal bladder function as demonstrated by UDSs. Of the 56 (68%) patients
with NLUTD, 29 (51%) patients showed initially a normal UDS, but developed NLUTD in the follow-up,
19 (66%) of them spontaneously and another 10 (34%) in association with growth and development,
or surgery of inclusion cysts. Radiologic abnormalities (upper tract dilatation and vesico-uretero-renal
reflux) were seen in 15%, mainly patients with NLUTD. CONCLUSION Our results add an important
set of information to the existing body of evidence. The data reconfirm our earlier published favorable
preliminary results and support other studies that show a possible benefit of prenatal OSB repair on the
urological outcome, but they also demonstrate that the positive effect remains limited.
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Abstract
Introduction: Neurogenic lower urinary tract dysfunction 
(NLUTD) represents a severe burden for patients with open 
spina bifida (OSB). The effect of fetal OSB repair on the uro-
logical outcome remains unclear, as controversial data exist. 
The aim of this study was to further increment existing out-
come data and to demonstrate that our earlier published 
positive preliminary results are not erratic. Methods: Data 
from standardized urological follow-up appointments of pa-
tients with fetal OSB repair operated at our center were ana-
lyzed. Data were obtained from urodynamic studies (UDSs) 
and radiologic exams performed in the newborn (gestation-
al age 37–39 weeks), at ages of 6, 12, 18, and 24 months, and 
then at yearly intervals. Results: Of 82 patients (mean age 2.6 
years, range 6 months to 7 years), 26 (32%) had a normal 
bladder function as demonstrated by UDSs. Of the 56 (68%) 
patients with NLUTD, 29 (51%) patients showed initially a 
normal UDS, but developed NLUTD in the follow-up, 19 
(66%) of them spontaneously and another 10 (34%) in asso-
ciation with growth and development, or surgery of inclu-
sion cysts. Radiologic abnormalities (upper tract dilatation 
and vesico-uretero-renal reflux) were seen in 15%, mainly 
patients with NLUTD. Conclusion: Our results add an impor-
tant set of information to the existing body of evidence. The 
data reconfirm our earlier published favorable preliminary 
results and support other studies that show a possible ben-
efit of prenatal OSB repair on the urological outcome, but 
they also demonstrate that the positive effect remains lim-
ited. © 2020 The Author(s)
Published by S. Karger AG, Basel
Introduction
Neurogenic lower urinary tract dysfunction (NLUTD) 
represents a severe burden for patients with open spina 
bifida (OSB). Although modern urological management 
allows preserving renal function in the majority of cases, 
it is only achieved with a negative impact on quality of 
life.
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In the last years, in utero repair of OSB has become a 
treatment option for selected patients [1]. The rationale 
for in utero repair is the preservation of neurologic func-
tion by protecting the spinal cord from secondary dam-
age during gestation [2]. While the MOMS trial demon-
strated [3] (and our center delivered confirmative data 
[1]) that fetal OSB repair indeed is able to preserve neu-
rologic lower extremity function and dramatically de-
creases rates of shunt-dependent hydrocephalus, the ef-
fect on the urological outcome remains unclear. Several 
studies on the urological outcome after in utero OSB re-
pair were published [4–17], however reporting contro-
versial results. The aim of this study was to further incre-
ment urological outcome data by analyzing our own co-
hort of patients who underwent in utero OSB repair, and 
to demonstrate that our earlier published positive pre-
liminary results [7] are permanent.
Material and Methods
Data of 82 pediatric patients who underwent in utero OSB re-
pair performed at the Zurich Center for Fetal Diagnosis and Ther-
apy (www.swissfetus.ch) and who had at least a follow-up of 6 
months were analyzed. The Zurich Spina Bifida Center provides a 
standardized follow-up for all patients operated at our institution, 
and follow-up data are collected prospectively using a registry cre-
ated with REDCap. Urological follow-up exams include detailed 
history of micturition pattern, clean intermittent catheterization 
(CIC), anticholinergic use, urinary tract infections (UTIs), urody-
namic studies (UDSs), and renal ultrasound at all appointments. 
VCUG is obtained as baseline at the initial work-up and when 
clinically indicated.
We analyzed the data obtained from exams performed in the 
first 2 weeks of life (corrected for prenatal birth after a gestational 
age of 37 weeks), at 6, 12, 18, and 24 months, and then at yearly 
intervals. Further, history of postnatal spinal cord surgery was ex-
tracted from the registry. UDSs were performed in a standardized 
way according to the International Children’s Continence Society 
[18] as described earlier elsewhere [7]. Based on micturition be-
havior and UDS findings, normal bladder was defined by the pres-
ence of a stable detrusor during filling, detrusor contraction lead-
ing to voiding, normal compliance, normal capacity for age, nor-
mal bladder sensation in older children, and no residual urine. 
Patients were treated according to current guidelines [19, 20].
Results
Eighty-two patients (mean age 2.6 years, range 6 
months to 7 years, 59 females, 33 males) were analyzed. 
Twenty-six (32%) of these 82 patients showed a normal 
UDS at their last exam. In the newborn period, UDS was 
normal in 66% (54/82). At age 6 months, the UDS dem-
onstrated in 51% (41/81) a normal bladder function. Of 
the patients who went through the first-year follow-up, 
43% (35/81) had a normal bladder function, and of the 
ones who went through the second-year follow-up, 34% 
(20/58) had a normal bladder function. Thirty-five pa-

























Results of UDS at follow-up appointments
Normal bladder function 54 41 35 26 20 6 3 2 2
Neurogenic lower urinary 
tract dysfunction
28 40 46 42 38 29 18 10 5 1
Number of patients 82 81 81 68 58 35 21 12 7 1
Fig. 1. Columns visualize the proportion of patients with normal 
bladder function to those with NLUTD at each follow-up appoint-
ments. The proportion becomes less representative in the older 
age groups due to the decreasing number of patients. NLUTD, 




Fetal Diagn Ther 2020;47:882–888884
DOI: 10.1159/000509392














































































78 L5 L4 Neurogenic lower urinary tract dysfunction








Timepoints of follow-up urodynamic studiesAnatomical
level 
2
(For legend see next page.)
Urological Outcome after Fetal Spina 
Bifida Repair
885Fetal Diagn Ther 2020;47:882–888
DOI: 10.1159/000509392
tients had undergone the 3-year follow-up, and the per-
centage of patients with normal bladder function was 
17% (6/35). The 3 patients who were older than 4 years 
and demonstrated a normal UDS voided volitionally with 
dry intervals. One of these 3 patients developed NLUTD 
after inclusion cyst resection and required thereafter CIC 
and anticholinergic medication (see below). Figure 1 de-
picts the number of patients who went through each fol-
low-up exam and the distribution of patients with normal 
bladder and NLUTD.
The dynamics of neurourologic changes are illustrated 
in Figure 2. It lists all 82 patients in chronological order 
with the respective UDS results from each follow-up ap-
pointment. 23% (19/82) had initially a normal bladder 
function but showed in the follow-up a spontaneous de-
terioration to NLUTD (14 within the first 12 months, 4 
between 12 and 18 months, and 1 between 18 and 24 
months). Another 12% (10/82) developed NLUTD in as-
sociation with inclusion cysts (at the mean age of 2.0 
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Fig. 3. a Patients with normal UDSs showed 
rarely radiologic changes such as upper 
tract dilatation, VUR, and bladder wall 
thickening. The diagram indicates num-
bers of patients at each interval found with 
radiologic changes. b In contrast to pa-
tients with normal UDSs (a), patients with 
NLUTD showed more frequently radiolog-
ic changes. NLUTD, neurogenic lower uri-
nary tract dysfunction; UDS, urodynamic 
study; VUR, vesico-uretero-renal reflux.
Fig. 2. Dynamics of neurourologic changes. All patients are listed 
in chronological order with the respective UDS results from each 
follow-up appointment. Twenty-nine patients who had initially a 
normal UDS showed in the follow-up a NLUTD. The asterisks in-
dicate neurosurgical resections of inclusion cysts. Note that of the 
12 patients with resection of inclusion cysts, 7 had a normal blad-
der function up to the intervention, while in 3 patients, new occur-
rence of NLUTD prompted inclusion cyst resection. None of these 
10 patients regained normal bladder function. The anatomic level 
in the table was retrieved from the first postnatal MRI and is de-
fined by the first dysraphic vertebra. The functional level in the 
table is the first one diagnosed by a pediatric neurologist. The func-
tional level may vary throughout the follow-up. NLUTD, neuro-
genic lower urinary tract dysfunction; UDS, urodynamic study.
Mazzone/Hölscher/Moehrlen/Gobet/
Meuli/Horst
Fetal Diagn Ther 2020;47:882–888886
DOI: 10.1159/000509392
ic deterioration preceded diagnosis and neurosurgical re-
section of inclusion cysts. In 8.5% (7/82), NLUTD devel-
oped only after neurosurgical inclusion cyst resection; be-
fore surgery, the bladder function had been normal. None 
of these patients regained normal bladder function. One 
additional patient (1.2%) regained normal bladder func-
tion after cyst resection (at the age of 4.9 years) and after 
an initial period of spinal shock. Febrile urinary tract in-
fections occurred in 27 patients (33%). All but 3 were pa-
tients with NLUTD.
The frequency of abnormal radiologic findings such as 
vesico-uretero-renal reflux (VUR), upper tract dilatation, 
and bladder wall thickening is reported in Figure 3a and 
b. These abnormalities mainly occurred in patients with 
NLUTD (Fig. 3b). Additional urological findings in our 
cohort were posterior urethral valves (n = 1), hypodys-
plastic kidneys (n = 3), and distal hypospadias (n = 1).
Treatment of NLUTD offered to our patients included 
CIC, anticholinergic therapy, and intradetrusor botulinum 
A toxin injection, ureterocutaneostomy, vesicostomy, and 
continence surgery. Details are reported in Table 1.
Discussion
The study presented here indicates that fetal OSB re-
pair may have a positive effect on the lower urinary tract 
function, albeit limited. We found a higher percentage of 
patients with normal bladder function than percentages 
known from the literature after postnatal repair. In our 
cohort, 66% (54/82) newborns showed a normal UDS, 
while in newborns who had undergone postnatal OSB re-
pair, UDSs were reported normal only in 12% [21] to 32% 
[22, 23]. Yet, a matter of concern is the finding that the 
percentage of normal bladder function decreases quite 
dramatically with time. In our cohort, the percentage of 
normal UDSs diminished from the mentioned 66% 
(54/82) to 51% (42/82) at 6 months and 43% (35/81) at 1 
year. Moreover, 23% (19/82) who had initially a normal 
bladder function developed spontaneously NLUTD dur-
ing follow-up (74% in the first year). In addition, 12% 
(10/82) exhibited NLUTD in association with the devel-
opment and surgery of inclusion cysts (at the mean age of 
2.0 years). (We have reported earlier on the unexpectedly 
high occurrence of inclusion cysts after fetal OSB repair 
with loss of neurologic function [24].)
Changes in neurourologic status in the follow-up have 
also been described in patients with postnatal OSB repair. 
Sillén et al. [22] investigated infants with postnatal OSB 
repair urodynamically 3 times during their first year of 
life: changes in the urodynamic pattern occurred mainly 
in the first 4 months, and the main feature was an increase 
of detrusor activity, seen in 40% of the infants. Spindel et 
al. [25] noted neurourologic changes in 37% (29/79) of 
patients, usually occurring within the first 12 months, 
with 18% (15/79) showing deterioration. Nevertheless, 
despite the decreasing percentage of normal bladder 
function with age, we still found a higher number of pa-
tients with normal UDSs at older ages than patients with 
postnatal care. At the age of 3 years and older, 17% (6/35) 
of patients had normal UDSs. After postnatal OSB repair, 
normal bladder function was found in 5% of patients be-
yond the age of toilet training [26].
Radiologic abnormalities of the upper tract (upper 
tract dilatation and VUR) are aftermaths of unfavorable 
urodynamics (high-risk bladders with poor compliance, 
high leak point pressures, and hyperactivity), marking 
deterioration of the upper urinary tract [20, 22]. In our 
cohort, radiologic abnormalities (upper tract dilatation 
and VUR) were seen in 15% of the patients, and these 
were, as expected, mainly patients with NLUTD. This 
small percentage might indirectly support a positive ef-
fect of fetal OSB repair on the lower urinary tract. After 
postnatal OSB repair, hydronephrosis and VUR have 
been found in higher percentages (7–30% [27] and 20% 
[27] to 35% [22]). Sillén et al. [22] who diagnosed VUR in 
35% (12/34) demonstrated the strong correlation be-
tween VUR and unfavorable urodynamics. However, in 
patients with postnatal OSB repair, upper tract dilatation 
may initially also be secondary to temporary urinary re-
tention due to spinal shock.
Overall, in comparison to patients with postnatal OSB 
repair, the higher percentage of normal bladder function 
and low percentage of radiologic abnormalities found in 
our cohort across the different ages are promising. Our 
actual results confirm in part our short-term results pub-
lished previously [7]. There, prospective comparison of 8 
Table 1. Summary of NLUTD treatments
Therapy of NLUTD (N = 56, 68%) N %
CIC only 12 14
CIC + anticholinergic therapy 42 51
+ Intradetrusor botulinum A toxin injection 7 8.5
Ureterocutaneostomy 1 1.2
Vesicostomy 1 1.2
Continence surgery (sling) 1 1.2
CIC, clean intermittent catheterization; NLUTD, neurogenic 
lower urinary tract dysfunction.
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patients each with prenatal versus postnatal repair showed 
at age 2 years that only 50% of the prenatal surgery pa-
tients, but 100% of postnatal surgery patients, had lower 
urinary tract dysfunction (p = 0.077). The latter had also 
more bladder trabeculation and thicker bladder walls, 
while the former required significantly less CIC and anti-
cholinergic medication.
Only few other studies described a positive urologic im-
pact of fetal OSB repair. Carr et al. [6] reported on a 5-year 
follow-up of patients undergoing prenatal closure before 
the MOMS trial; 18.5% of fetal surgery patients demon-
strated volitional voiding and continence, compared with 
8.3% of patients in a historical group of postnatally repaired 
patients. Brock et al. [5] reported the results of the urologi-
cal outcome in the MOMS patients (prenatal and postnatal 
surgery groups) in a first study published in 2015 [4] with 
data obtained at 30 months of age and in a second one pub-
lished in 2019 with a mean follow-up of 7.4 years. In this last 
one, patients of the prenatal group showed more frequent-
ly spontaneous voiding (24 vs. 4%, p < 0.001) and required 
less CIC (62 vs. 87%, p < 0.001). Further, the prenatal group 
was on less bladder medication at the last follow-up. Inter-
estingly, and in contrast to our study, videourodynamics or 
findings on renal/bladder ultrasound were, aside from a 
larger post-void residual urodynamic catheterization vol-
ume in postnatally operated patients, not statistically differ-
ent. Pastuszka et al. [17] evaluated 36 patients with prenatal 
repair and 36 patients with postnatal repair, all treated at the 
same center with the same management after birth. As in 
Brock’s study, but in contrast to our findings, urodynamics 
and imaging studies showed no differences between the 
groups. However, the authors concluded that prenatal OSB 
repair ensures statistically significant improvement of the 
degree of social urinary continence, reducing the risk of 
UTI and constipation.
On the other hand, several studies suggested little ben-
efit of prenatal OSB repair concerning the urinary tract. 
The group of Macedo published several studies [12, 14, 
15, 28, 29] of prospectively followed up patients with pre-
natal OSB repair and a high incidence of abnormal blad-
der patterns. In an analysis of 100 patients [15], only 15% 
showed a normal bladder profile at a mean age of 5.8 
months (median 4 months). This low percentage strong-
ly contrasts with the results of our cohort. Moreover, 5 
other retrospective observational studies showed no sig-
nificant improvements in lower urinary tract function af-
ter fetal OSB repair [8–11, 16]. However, these studies 
had serious limitations such as selection or treatment 
bias, the retrospective and non-controlled study design, 
and different outcome measurements.
The main limitation of the present study is that it is 
based prevalently on UDSs in infants and toddlers. Per-
forming and interpreting UDSs in this age group is noto-
riously difficult as is comparison of results among studies. 
Also, only few patients are clearly beyond the toilet train-
ing period, and not only the rates of normal bladder func-
tion with normal urodynamic patterns but also volitional 
voids and dry intervals cannot be determined. Further, 
these older age groups are too small to draw conclusions. 
However, this study has the strength to analyze a large 
number of patients and to rely on a cohort with a stan-
dardized, almost gapless, prospective follow-up, done by 
a team of highly qualified and experienced examiners.
Future studies will have to reexplore the urological out-
come when the cohort of children aged 6–7 years has be-
come bigger. Other studies will have to investigate on which 
patients actually benefit from prenatal OSB repair and why, 
and on how these benefits can be further improved. In con-
clusion, we produce sound evidence for a clear-cut, but lim-
ited, benefit of prenatal OSB repair on urologic outcomes.
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